Delivery Order SPE2DB25D3404-SPE2DB25FUMZY

Award Date 4/17/25
Potential Completion Date 5/8/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,975.58 contract is for the supply of BENLYSTA 200 MG/ML autoinjectors, a medication used to treat lupus. The award has an ultimate completion date of May 6, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,975.58, is for the delivery of BENLYSTA 200 mg/mL autoinjector, a medication used to treat lupus. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,975.58 firm-fixed-price contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication, with a period of performance through June 10, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a medication used in the treatment of systemic lupus erythematosus. The contract has a ceiling value of $4,987.78 and is a firm fixed-price contract with a period of performance through May 21, 2025. The contract is not a set-aside and was...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,975.58 firm fixed price contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a prescription medication. The delivery order has a completion date of June 9, 2025 and is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $9,248.01 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a medication, with a period of performance through July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,987.78 firm fixed-price contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a medication used in the treatment of autoimmune diseases. The contract has an ultimate completion date of May 29, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a $8,379.09 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to support military treatment programs and facilities. The contract has an ultimate completion date of September 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,975.58 firm fixed-price contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR medical products. The contract is not set aside and has an ultimate completion date of June 16, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,152.80, is for the delivery of 4,568,147,289 units of BENLYSTA 200 MG/ML SYRINGE/ML, a medication used in the treatment of lupus. The contract has an ultimate completion date of May 27, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMZY
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,975.58 fixed-price contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a medication used to treat lupus. The contract has a performance period through May 2025 and is not a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 7/17/25, 2:05 PM